Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Katie L Wallace"'
Autor:
C. Tyler Pitcock, Aric Schadler, David S. Burgess, Donna R. Burgess, Sarah E. Cotner, Jeremy Van Hoose, Eric R. Gregory, Katie L. Wallace
Publikováno v:
Antimicrobial Stewardship & Healthcare Epidemiology, Vol 3 (2023)
Abstract Objective: Vancomycin therapy is associated with an increased risk of acute kidney injury (AKI). Previous studies suggest that area under the curve (AUC) monitoring reduces the risk of AKI, but literature is lacking to support this in patie
Externí odkaz:
https://doaj.org/article/438f7acd355d47259c9169799d8deb4c
Autor:
Elisabeth L. Chandler, Katie L. Wallace, Elizabeth Palavecino, James R. Beardsley, James W. Johnson, Vera Luther, Christopher Ohl, John C. Williamson
Publikováno v:
Antimicrobial Stewardship & Healthcare Epidemiology, Vol 2 (2022)
Abstract Objective: To compare 2 methods of communicating polymerase chain reaction (PCR) blood-culture results: active approach utilizing on-call personnel versus passive approach utilizing notifications in the electronic health record (EHR). Des
Externí odkaz:
https://doaj.org/article/7b487781fce34f5fa87ee071890a8e1b
Autor:
Connor M. Anderson, Jeremy D. VanHoose, Donna R. Burgess, David S. Burgess, Aric Schadler, J. Zachary Porterfield, Katie L. Wallace
Publikováno v:
Antimicrobial Stewardship & Healthcare Epidemiology, Vol 2 (2022)
Abstract Objective: The objective of this study was to determine antibiotic appropriateness based on Loeb minimum criteria (LMC) in patients with and without altered mental status (AMS). Design: Retrospective, quasi-experimental study assessing po
Externí odkaz:
https://doaj.org/article/19d27f3047754755aadb3004eee5e74c
Autor:
Alexander H. Flannery, Katie L. Wallace, Christian N. Rhudy, Allison S. Olmsted, Rachel C. Minrath, Stuart M. Pope, Aaron M. Cook, David S. Burgess, Peter E. Morris
Publikováno v:
Therapeutic Advances in Infectious Disease, Vol 8 (2021)
Background: While vancomycin loading doses may facilitate earlier pharmacokinetic–pharmacodynamic target attainment, the impact of loading doses on clinical outcomes remains understudied. Critically ill patients are at highest risk of morbidity and
Externí odkaz:
https://doaj.org/article/0f0650b45efd422892e51db25aeace57
Autor:
Katie B. Olney, Katie L. Wallace, Ryan P. Mynatt, David S. Burgess, Kaitlyn Grieves, Austin Willett, Johann Mani, Alexander H. Flannery
Publikováno v:
Pharmacotherapy
INTRODUCTION: Consensus guidelines recommend targeting a vancomycin area under the curve to minimum inhibitory concentration (AUC(24):MIC) ratio of 400-600 to improve therapeutic success and reduce nephrotoxicity. Although guidelines specify either B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64fdbfb863ef0f6a1d1f0d14b6c2b0e1
https://europepmc.org/articles/PMC9750735/
https://europepmc.org/articles/PMC9750735/
Autor:
Elisabeth L. Chandler, Katie L. Wallace, Elizabeth Palavecino, James R. Beardsley, James W. Johnson, Vera Luther, Christopher Ohl, John C. Williamson
Publikováno v:
Antimicrobial stewardshiphealthcare epidemiology : ASHE. 2(1)
Objective: To compare 2 methods of communicating polymerase chain reaction (PCR) blood-culture results: active approach utilizing on-call personnel versus passive approach utilizing notifications in the electronic health record (EHR). Design: Retrosp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::521ad3c0e94100297a12adfb7b319d9c
https://pubmed.ncbi.nlm.nih.gov/36483427
https://pubmed.ncbi.nlm.nih.gov/36483427
Autor:
Arnold J. Stromberg, Ryan P. Mynatt, Nannan Li, Jeremy VanHoose, David S. Burgess, Heather D'Amico, Donna R. Burgess, Katie L Wallace, Sarah Cotner
Publikováno v:
Antimicrob Agents Chemother
Vancomycin is a first-line agent used in the treatment of methicillin-resistant Staphylococcus aureus; however, vancomycin is associated with acute kidney injury (AKI). Previous literature demonstrates decreased incidence of AKI using 24-h area under
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cb7e6f3fc6c327b09b211da20be02d5
https://pubmed.ncbi.nlm.nih.gov/34633843
https://pubmed.ncbi.nlm.nih.gov/34633843
Autor:
Jeremy VanHoose, Katie L Wallace, Donna R. Burgess, David S. Burgess, Derek W Forster, Sarah Cotner, Elizabeth B. Autry, Alexander H. Flannery, Brian Gardner, Eric R. Gregory
Publikováno v:
Journal of Pharmacy Practice. 34:272-278
Background:Evidence suggests the standard vancomycin trough goal of 15 to 20 mg/L for serious Staphylococcus aureus infections is associated with acute kidney injury, whereas appropriate monitoring of 24-hour area under the curve (AUC) may decrease n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac4e66b98aec7df3a7d1d97038750562
https://doi.org/10.1177/0897190019867494
https://doi.org/10.1177/0897190019867494
Autor:
Alexander H, Flannery, Katie L, Wallace, Christian N, Rhudy, Allison S, Olmsted, Rachel C, Minrath, Stuart M, Pope, Aaron M, Cook, David S, Burgess, Peter E, Morris
Publikováno v:
Therapeutic Advances in Infectious Disease
Background: While vancomycin loading doses may facilitate earlier pharmacokinetic–pharmacodynamic target attainment, the impact of loading doses on clinical outcomes remains understudied. Critically ill patients are at highest risk of morbidity and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bd47d0b226908f17ee7bc990745d76e8
https://pubmed.ncbi.nlm.nih.gov/33854772
https://pubmed.ncbi.nlm.nih.gov/33854772
Autor:
David S. Burgess, Alexander H. Flannery, Katie L Wallace, Samuel A. Effoe, Natalie L. Delozier, Aaron M. Cook
Publikováno v:
PharmacotherapyReferences. 40(12)
Background Early attainment of target area under the curve (AUC) to minimum inhibitory concentration (MIC) ratios have been associated with clinical success, as well as lower incidence of acute kidney injury (AKI), in patients receiving vancomycin fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a642c206f050711f40f1d513e2656101
https://pubmed.ncbi.nlm.nih.gov/33176005
https://pubmed.ncbi.nlm.nih.gov/33176005